LX Bioboost Plus Pre-filled Syringe Recalled for Sterility Assurance
Thrive Health Solutions is recalling LX Bioboost Plus pre-filled syringes due to lack of assurance of sterility. The affected product is a multi-ingredient injectable formulation distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class II recall with lack of sterility assurance on a parenteral injection product represents a serious potential health hazard. Sterility failures in injectable pharmaceuticals can result in life-threatening infections and warrant hospitalization.
Plain-English summary
Thrive Health and Wellness, LLC, dba Thrive Health Solutions, is recalling LX Bioboost Plus pre-filled syringes. Each 1mL syringe contains Methionine 25 mg, Inositol 50 mg, Choline Chloride 50 mg, Pyridoxine HCl 25 mg, Dexpanthenol 25 mg, Cyanocobalamin 1 mg, L-Arginine HCl 15 mg, L-Carnitine 15 mg, and Lidocaine 1 mg in SWFI (sterile water for injection).
The recall is being issued because the manufacturer cannot assure the sterility of the product. Affected lot numbers are H227226 (Exp 12/24/2025), H360175 (Exp 6/2/2025), H368308 (Exp 6/2/2025), and S360175 (Exp 6/2/2025). A total of 102 syringes has been distributed nationwide.
Consumers and healthcare providers who have received this product should stop using it immediately. Anyone who has used the product and has questions or concerns should contact Thrive Health Solutions at 88 Inverness Circle East, Suite A-204, Englewood, CO 80112.
The recalled product
- Product
- LX Bioboost Plus, (Each 1mL contains Methionine 25 mg, Inositol 50 mg, Choline Chloride 50 mg, Pyridoxine HCl 25 mg, Dexpanthenol 25 mg, Cyanocobalamin 1 mg, L-Arginine HCl 15 mg, L-Carnitine 15 mg, and Lidocaine 1 mg in SWFI), pre-filled syringe, Thrive Health Solutions, 88…
- Category
- Drug — Injectable / Compounded
- Affected units
- 102
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: H227226
- Exp 12/24/2025
- H360175
- Exp 6/2/2025
- H368308
- Lot S360175
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 14 recalled by Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
See all →- SevereLL Bioboost Injectable pre-filled syringes recalled for lack of sterility assurance
FDA (Drugs) · 2025-07-02
- ModerateTirzepatide Injections Pre-filled Syringe Recalled for Sterility Assurance
FDA (Drugs) · 2025-07-02
- SevereTirzepatide Injections recalled due to lack of sterility assurance
FDA (Drugs) · 2025-07-02
- SevereSemaglutide/Cyanocobalamin Injectable Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2025-07-02
- SevereSemaglutide pre-filled syringe recalled due to sterility concerns
FDA (Drugs) · 2025-07-02
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SeverePromise Pharmacy Recalls Trim Complete Injection Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- HighCompounded pharmaceutical vials recalled due to sterility assurance failure
FDA (Drugs) · 2022-06-01
- HighLipo-Mino-Mix Injectable Compounded Drug Recalled for Sterility Assurance Failure
FDA (Drugs) · 2022-06-01
- HighInjectable drug recalled for lack of sterility assurance
FDA (Drugs) · 2022-06-01
- HighPyridoxine Injection Solution Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2024-10-02
- HighInjectable Lidocaine Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-27